FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 26

Author

Admin 422 posts 0 comments

Webinar

How Growing Organizations Accelerate Their Modern Accounting Journey

Admin May 8, 2025
Increasing complexity and changing business priorities are nothing new for growing organizations, but these…
Webinar

How to generate business growth with subscriptions

Admin May 6, 2025
Recent economic developments have highlighted the need for companies to be adaptable. With subscriptions, you can…
Articles

Unlocking the Next-Level of Fast Disbursements

Admin May 5, 2025
We live in a world where time and speed are of the essence. Fast payments have become ubiquitous across several…
Articles

Understanding the Importance of Credit Scores in Personal Finance

Admin May 2, 2025
In today’s financial world, your credit score is more than just a number—it’s a powerful tool that affects…
Articles

Capital Management in the B2B Industry: A Strategic Approach to Financial…

Admin Apr 30, 2025
In the fast-paced and competitive landscape of Business-to-Business (B2B) industries, effective capital…
Articles

What’s Going On in the Fintech Industry?

Admin Apr 29, 2025
The fintech industry is evolving rapidly, driven by innovation, regulation, and growing consumer demand…
Featured News

Strategic Storage Trust VI Completes Loan Refinancing

Admin Apr 28, 2025
Strategic Storage Trust VI, Inc. (SST VI), a self-storage-focused real estate investment trust (REIT), has…
Webinar

Webinar | 1 May 2025 | Banking on agentic AI: The future of autonomous financial…

Admin Apr 25, 2025
Date: Thursday, 1 May 2025 Time: 2:00 PM BST | 09:00 AM EDT Agentic AI is poised to transform financial…
Featured News

ATEC Announces 2024 Financial Results and 2025 Growth Outlook

Admin Apr 24, 2025
Alphatec Holdings (ATEC) Reports Robust 2024 Financial Results and Projects Strong Growth for 2025 CARLSBAD,…
Articles

The Rise of Digital Lending: How Fintech is Revolutionizing Borrowing

Admin Apr 23, 2025
In today’s fast-paced digital economy, traditional loan processes—filled with paperwork, long approval…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • India’s Financial Revolution in 2026: How Digital Payments, Investments, and New Policies Are Reshaping the Economy
    • How to generate business growth with subscriptions
    • Understanding Banking Loans: A Comprehensive Guide
    • Understanding Credit Card Frauds: Types, Impact, and Prevention
    • Blackhawk Network Buys DIDIX Gifting & Promotions, a Dutch Company

    ARTICLE

    Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
    2026-06-29T06:36:41Z
    COPENHAGEN, Denmark, June 29, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on June 2, 2026, under which the Company will repurchase shares...


    Zelluna ASA activates The Royal Marsden as second clinical site for ZIMA-101, expanding clinical execution capabilities
    2026-06-29T06:30:00Z
    Oslo, 29 June 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today announced that The Royal...


    AB Science reports completion of the step 3 of phase 1, evaluating the combination of AB8939 with venetoclax for the treatment of refractory or relapsed AML
    2026-06-29T05:59:49Z
    PRESS RELEASE


    Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine
    2026-06-29T05:30:00Z
    COPENHAGEN, Denmark, June 29, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Health Canada has approved VIMKUNYA® (recombinant, adsorbed) for immunization to prevent disease caused by chikungunya virus...


    Roche announces the launch of AXELIOS 1, a transformative next-generation sequencing platform
    2026-06-29T05:00:00Z
    Basel, 29 June 2026 — Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today the launch of AXELIOS 1 based on the innovative SBX technology, with a unique combination of accuracy,...


    Ipsen to acquire Kartos Therapeutics, expanding hemato-oncology late-stage pipeline
    2026-06-29T05:00:00Z
    PARIS, FRANCE AND REDWOOD CITY, U.S., 29 JUNE 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) and Kartos Therapeutics, announced today they have entered into a definitive merger agreement under which...


    BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia
    2026-06-28T20:00:00Z
    - Phase 3 PROPEL 3 data published today in NEJM were simultaneously presented at ICCBH in a late-breaking oral presentation; presentation includes new arm span Z-score data showing a statistically...


    TBoostExperts.com Announces Availability of 2026 Consumer Report on Testosterone Booster Supplements and Men’s Health Supplement Evaluation
    2026-06-27T16:42:53Z
    New report provides an educational framework for reviewing testosterone booster supplements, ingredient transparency, supplement labels, consumer safety considerations, and responsible product research.


    BurnTide Official Announces 2026 In Across The USA, UK, CA and AU Effective Formula Burn Tide Gummies For Weight Loss in Markets
    2026-06-27T11:46:05Z
    Announcing BurnTide Gummies, a natural supplement designed to complement healthy weight loss. Learn how Burn Tide fits into a balanced diet, active lifestyle, and daily wellness routine.


    Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
    2026-06-26T22:29:14Z
    LIKMEZ® (ATI-1501) commercial momentum building in U.S. marketUS$40 million NIAID award supporting VXV-01 advancement through Phase 1


    Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance
    2026-06-26T21:15:00Z
    BEDMINSTER, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on June 24, 2026, it received a notice (the “Notice”)...


    Nordic Naturals Ultimate Omega Featured in New Erewhon Smoothie by J Balvin
    2026-06-26T20:36:00Z
    Watsonville, CA, June 26, 2026 (GLOBE NEWSWIRE) -- Nordic Naturals, the #1 selling fish oil brand in the U.S.‡, today announced that its award-winning Ultimate Omega® is a featured ingredient...


    VitalHub Announces Results of Annual General Meeting of Shareholders
    2026-06-26T20:30:00Z
    TORONTO, June 26, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the voting results from its annual general meeting of shareholders held virtually on...


    Crescent Biopharma Announces Grants of Inducement Awards
    2026-06-26T20:15:00Z
    WALTHAM, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies...


    Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
    2026-06-26T20:15:00Z
    Neuphoria Therapeutics confirms it is in talks with Scancell Holdings plc about a possible combination


    Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
    2026-06-26T20:05:00Z
    Ji'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the...


    Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
    2026-06-26T20:05:00Z
    WILMETTE, Ill., June 26, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs,...


    Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia
    2026-06-26T20:05:00Z
    BALA CYNWYD, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that...


    Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®
    2026-06-26T20:01:00Z
    COPENHAGEN, Denmark, June 26, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Company has been added to the broad-market Russell 3000® Index, the large-cap Russell...


    Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from the California Institute for Regenerative Medicine (CIRM) to Support Clinical Development of SRN-101 in High-Grade Glioma
    2026-06-26T17:20:00Z
    SAN FRANCISCO, June 26, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the California Institute for Regenerative Medicine (CIRM) has awarded the...


    Johnson & Johnson presents new IMAAVY®▼ (nipocalimab) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalised myasthenia gravis
    2026-06-26T16:45:01Z
    BEERSE, BELGIUM, June 26, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced new data across 12 abstracts at the European Academy of Neurology (EAN) 2026 Congress that offer additional...


    Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units
    2026-06-26T16:30:00Z
    CHICAGO, June 26, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced a distribution agreement with International...


    FDA Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers Accountable, Protect Public Health
    2026-06-26T15:33:16Z
    If finalized, rule would level the playing field between American and foreign businesses


    Board decision to file for bankruptcy
    2026-06-26T15:15:00Z
    Ghent, June 26, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE | REGULATED INFORMATION - INSIDE INFORMATION26 June 2026, 05:15 pm CEST


    Readout from Legacy Ultimovacs DOVACC Phase II Trial Concludes UV1 Programme as Previously Guided
    2026-06-26T14:40:00Z
    Oslo, 26 June 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today announces that...


    Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
    2026-06-26T14:02:35Z
    –Advisory Committee meeting scheduled for July 29, 2026––Company's Biologics License Application on track with PDUFA target action date of August 22, 2026–


    New Yorkers Celebrate Independence Through Helen Keller's Legacy at Premiere of Groundbreaking Documentary Possibilities
    2026-06-26T13:50:17Z
    Blind artists, educators, advocates, and creatives gather on Helen Keller's 146th birthday ahead of America's 250th anniversary


    Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes
    2026-06-26T13:15:00Z
    RESEARCH TRIANGLE PARK, N.C., June 26, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision...


    Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference
    2026-06-26T13:05:00Z
    SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced positive five-year data from...


    Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress
    2026-06-26T13:00:00Z
    New results from HMB-002 first-in-human data validate proof of mechanism in Von Willebrand disease (VWD), elevating Von Willebrand Factor (VWF) and Factor VIII (FVIII) levels with subcutaneous dosing; multiple dose...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.